These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 7538196
1. Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism. Schaad NC, Vanecek J, Rodriguez IR, Klein DC, Holtzclaw L, Russell JT. Mol Pharmacol; 1995 May; 47(5):923-33. PubMed ID: 7538196 [Abstract] [Full Text] [Related]
2. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS. J Clin Invest; 1998 Feb 15; 101(4):812-8. PubMed ID: 9466976 [Abstract] [Full Text] [Related]
6. See-saw signal processing: reciprocal effects of stimulus deprivation on vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate accumulation in rat pinealocytes. Chik CL, Ho AK. Endocrinology; 1991 Feb 15; 128(2):850-6. PubMed ID: 1846590 [Abstract] [Full Text] [Related]
8. Interaction between prostaglandin E2 and l-cis-diltiazem, a specific blocker of cyclic nucleotide gated channels in bovine aortic endothelial cells. Shalom R, Barki-Harrington L, Rimon G. Eur J Pharmacol; 2006 Aug 14; 543(1-3):8-13. PubMed ID: 16842773 [Abstract] [Full Text] [Related]
9. Inhibitory effects of ethanol on the calcium-dependent potentiation of vasoactive intestinal peptide-stimulated cAMP and cGMP accumulation in rat pinealocytes. Chik CL, Ho AK. Biochem Pharmacol; 1991 Sep 27; 42(8):1601-8. PubMed ID: 1656991 [Abstract] [Full Text] [Related]
10. Inhibition of vasoactive intestinal peptide (VIP) binding on human melanoma cells IGR39 by nitric oxide: cGMP is not involved. Fouchier F, Pichon J, Forget P. Eur J Cell Biol; 1994 Jun 27; 64(1):71-7. PubMed ID: 7957315 [Abstract] [Full Text] [Related]
11. Regulation of prolactin gene expression by vasoactive intestinal peptide and dopamine in the turkey: role of Ca signalling. Al Kahtane A, Kannan M, Kang SW, El Halawani ME. J Neuroendocrinol; 2005 Oct 27; 17(10):649-55. PubMed ID: 16159377 [Abstract] [Full Text] [Related]
12. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. Ebihara Y, Karmazyn M. Cardiovasc Res; 1996 Sep 27; 32(3):622-9. PubMed ID: 8881523 [Abstract] [Full Text] [Related]
14. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart. Sawmiller DR, Henning RJ, Cuevas J, Dehaven WI, Vesely DL. Neuropeptides; 2004 Oct 27; 38(5):289-97. PubMed ID: 15464194 [Abstract] [Full Text] [Related]
15. Role of nitric oxide on ATP-induced Ca2+ signaling in outer hair cells of the guinea pig cochlea. Shen J, Harada N, Nakazawa H, Kaneko T, Izumikawa M, Yamashita T. Brain Res; 2006 Apr 07; 1081(1):101-12. PubMed ID: 16500627 [Abstract] [Full Text] [Related]
16. Differential involvement of the arachidonic acid cascade on the alpha 1-adrenergic potentiation of vasoactive intestinal peptide- versus beta-adrenergic-stimulated cyclic AMP and cyclic GMP accumulation in rat pinealocytes. Chik CL, Young I, Ho AK. J Neurochem; 1991 Nov 07; 57(5):1534-9. PubMed ID: 1655977 [Abstract] [Full Text] [Related]
17. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery. Kawasaki J, Kobayashi S, Miyagi Y, Nishimura J, Fujishima M, Kanaide H. Br J Pharmacol; 1997 Jul 07; 121(5):977-85. PubMed ID: 9222556 [Abstract] [Full Text] [Related]
18. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a beta-adrenergic receptor/cyclic AMP mechanism. Roseboom PH, Klein DC. Mol Pharmacol; 1995 Mar 07; 47(3):439-49. PubMed ID: 7700241 [Abstract] [Full Text] [Related]
19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009 [Abstract] [Full Text] [Related]
20. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. Xia M, Sreedharan SP, Bolin DR, Gaufo GO, Goetzl EJ. J Pharmacol Exp Ther; 1997 May 15; 281(2):629-33. PubMed ID: 9152366 [Abstract] [Full Text] [Related] Page: [Next] [New Search]